Us Bancorp \De\ Vbi Vaccines Inc Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 28, 2021	SELL	$2.91 - $4.32 $116 - $172	-40 Reduced 50.0%	40 $0
Q3 2020 Nov 10, 2020	SELL	$2.77 - $6.17 $3,988 - $8,884	-1,440 Reduced 94.74%	80 $0
Q2 2020 Aug 07, 2020	SELL	$0.87 - $3.13 $15,010 - $54,001	-17,253 Reduced 91.9%	1,520 $5,000
Q1 2020 May 13, 2020	BUY	$0.73 - $1.91 $5,315 - $13,908	7,282 Added 63.37%	18,773 $18,000
Q4 2019 Feb 04, 2020	BUY	$0.48 - $1.38 $5,515 - $15,857	11,491 New	11,491 $16,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.